CRITICAL
DISCOVERY
SCIENTIFIC
ADVANCEMENT
PATIENT
TREATMENT
ACGT is in the right place at the right time, leading the way for innovative research using cells and genes as "medicine."
Everyday, research progresses successfully from the laboratory to clinical translation, moving closer to a less debilitating, more effective treatment approach essential to the quality of life and survival of cancer patients.
ACGT is approved by the coalition of the Better Business Bureau and the National Charities Information Bureau for meeting the highest standards of governance, effectiveness, public communications and financial responsibility.
Send this page to a friend
RFA Announcement
-
2010 Young Investigator Award Research Grant
Abstract Deadline: August 16, 2010 at 4pm E.S.T.
Learn how to apply
Apply now - View Video: Alliance for Cancer Gene Therapy: Celebrating Progress
In our new video meet some of our ACGT researchers who are making medical history. ACGT has awarded 33 cancer research grants totaling $20 million dollars to support both discovery and translation of new therapies from laboratory to patient. View the video
Recent Publications & Resources
- ACGT's June 2010 Newsletter
- Greenwich Post's Article about the Swim Across America Event
- Cell Therapy Vaccine Approved for Prostate Cancer
- View the Sept 2009 Discover Magazine article about Gene Therapy
- View the Philanthropy Article Winter 2010 that highlights ACGT's work
- View the Feb 2010 eSequence - ACGT's newsletter
- See all publications ...